Concepedia

Greg O’Connor

GO

7

Publications

1.2K

Citations

7

H-Index

2004

Active since

Affiliations

AstraZeneca (United States)(Current)

Elixir Medical (United States)

Greg O’Connor is an author at AstraZeneca (United States) specializing in gene expression, medicine, and cell biology.

Top concepts

Publications per year

2004–2020

7

Publications

7

The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in <i>C. elegans</i>

Javier Apfeld, Greg O’Connor, Tom McDonagh et al. · Genes & Development · 2004 · 634 citations · Full text

Aging networks in <i>Caenorhabditis elegans</i>: AMP‐activated protein kinase (<i>aak‐2</i>) links multiple aging and metabolism pathways

Rory Curtis, Greg O’Connor, Peter S. DiStefano · Aging Cell · 2006 · 205 citations · Full text

, , +20

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies

Garrett W. Rhyasen, Maureen M. Hattersley, Yi Yao et al. · Molecular Cancer Therapeutics · 2016 · 147 citations · Full text

, , +17

Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response

Ben Sidders, Pei Zhang, Kelly Goodwin et al. · Clinical Cancer Research · 2020 · 96 citations

Advanced Oxidation Process for DNAN Using UV/H2O2

Hailei Su, Christos Christodoulatos, Benjamin Smolinski et al. · Engineering · 2019 · 27 citations · Full text

, , +18

Rows per page

1–5 of 7